Visual outcomes of photorefractive keratectomy in non-children with anisometropic amblyopia: One-year Follow-up Outcomes

医学 眼科 光折变性角膜切除术 立体视敏度 屈光参差 验光服务 折射误差 视力
作者
Mohammad Etezad-Razavi,Bahar Tafaghodi-Yousefi,Alireza Eslampour,Mohammad Yaser Kiarudi,Marzieh Najjaran,Hamed Momeni‐Moghaddam,Jorge L. Alió
出处
期刊:European Journal of Ophthalmology [SAGE Publishing]
卷期号:32 (5): 2615-2621 被引量:1
标识
DOI:10.1177/11206721211073033
摘要

Objective To evaluate the safety, efficiency, short term stability, and sensory results of photorefractive keratectomy (PRK) in anisometropic in non-compliant children with correction. Methods Twelve eyes of 12 children with an age range: 6–17 years and anisometropic amblyopia who underwent PRK under general anesthesia to correct the dioptric difference between the eyes were included in this study. A complete ophthalmic assessment including refractive status, uncorrected and corrected distance visual acuity (UDVA & CDVA), and binocular vision status using the Worth 4-dot test and stereopsis were performed before and 1, 3, 6, and 12 months after PRK. Results The mean preoperative CDVA was 0.34 ± 0.24 LogMAR which showed a statistically significant improvement at 12 months (0.20 ± 0.19, p = 0.024) after surgery compared to the preoperative assessment. (p = 0.003) The mean preoperative UDVA was 0.63 ± 0.24 LogMAR that increased to 0.44 ± 0.24, 0.32 ± 0.16, 0.25 ± 0.19, and 0.25 ± 0.19 LogMAR at 1, 3, 6, and 12 months after PRK, respectively. One to three lines improvement in UDVA and CDVA was seen in 10 (83.4%) and 8 eyes (66.7%); while one line UDVA and CDVA loss was seen in one (8.3%) and one (8.3%) eye and unchanged UDVA and CDVA was seen in 1 (8.3%) and 3 eyes (25%), respectively. The mean preoperative stereoacuity was 341.9 ± 245.7 s of arc, which significantly improved to 166.6 ± 87.5 s of arc 12 months after PRK. (p = 0.012) Conclusion PRK was an effective surgical alternative to improve visual acuity and stereopsis in anisometropic children who did not cooperate with conventional methods of amblyopia therapy.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
andy应助科研通管家采纳,获得10
1秒前
Soars应助张sir采纳,获得30
4秒前
不怕考试的赵无敌完成签到 ,获得积分10
5秒前
蔡从安完成签到,获得积分20
5秒前
看文献完成签到,获得积分10
7秒前
研友_O8Wz4Z完成签到,获得积分10
12秒前
啦啦啦啦啦完成签到,获得积分10
12秒前
空儒完成签到 ,获得积分10
13秒前
侠医2012完成签到,获得积分0
15秒前
16秒前
爱吃泡芙完成签到,获得积分10
16秒前
枕月听松完成签到,获得积分10
19秒前
黑眼圈完成签到 ,获得积分10
19秒前
wang完成签到 ,获得积分10
22秒前
刘亦菲暧昧对象完成签到 ,获得积分10
22秒前
郭小白完成签到 ,获得积分10
32秒前
Y2LSK完成签到,获得积分10
34秒前
li完成签到 ,获得积分10
35秒前
Lorry完成签到 ,获得积分10
35秒前
宁静致远QY完成签到,获得积分10
38秒前
曹广秀完成签到,获得积分10
41秒前
EvianLee完成签到 ,获得积分10
44秒前
八点必起完成签到,获得积分0
46秒前
hhhh777完成签到 ,获得积分10
49秒前
冷酷的枕头完成签到,获得积分10
49秒前
雨霧雲完成签到,获得积分10
54秒前
愉快立诚完成签到 ,获得积分10
54秒前
王鑫完成签到,获得积分10
56秒前
fuluyuzhe_668完成签到,获得积分10
1分钟前
浅影完成签到 ,获得积分10
1分钟前
苏222完成签到,获得积分20
1分钟前
Peter完成签到 ,获得积分10
1分钟前
耳冉完成签到 ,获得积分10
1分钟前
hhh完成签到 ,获得积分10
1分钟前
badyoungboy完成签到,获得积分10
1分钟前
PhH完成签到 ,获得积分10
1分钟前
南猫喵完成签到,获得积分10
1分钟前
霸气南珍完成签到,获得积分10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
PowerCascade: A Synthetic Dataset for Cascading Failure Analysis in Power Systems 2000
Various Faces of Animal Metaphor in English and Polish 800
Signals, Systems, and Signal Processing 610
Photodetectors: From Ultraviolet to Infrared 500
On the Dragon Seas, a sailor's adventures in the far east 500
Yangtze Reminiscences. Some Notes And Recollections Of Service With The China Navigation Company Ltd., 1925-1939 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6353195
求助须知:如何正确求助?哪些是违规求助? 8168047
关于积分的说明 17191522
捐赠科研通 5409215
什么是DOI,文献DOI怎么找? 2863646
邀请新用户注册赠送积分活动 1840978
关于科研通互助平台的介绍 1689834